1 St Source Bank Organon & Co. Transaction History

1 St Source Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$31.66 - $38.9 $7,281 - $8,947	-230 Reduced 3.33%	6,677 $225,000
Q1 2022 May 05, 2022	SELL	$30.45 - $39.36 $6,577 - $8,501	-216 Reduced 3.03%	6,907 $241,000
Q4 2021 Feb 09, 2022	SELL	$28.67 - $37.13 $7,167 - $9,282	-250 Reduced 3.39%	7,123 $217,000
Q3 2021 Nov 05, 2021	SELL	$28.63 - $35.64 $28,000 - $34,855	-978 Reduced 11.71%	7,373 $242,000
Q2 2021 Aug 03, 2021	BUY	$28.45 - $38.0 $237,585 - $317,338	8,351 New	8,351 $253,000

813

201M

1.53M

1.07M

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.91B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of 1 St Source Bank, based on Form 13F filings with the SEC.

Stay updated on 1 St Source Bank with notifications on news.